The Vasculitis Foundation encourages patients with vasculitis to participate in research when possible. Some studies are clinically based, others are being conducted by marketing research companies to help industry better understand disease activity.

A complete list of research studies can be found at ClinicalTrials.gov.  Once you are on the page, please enter “vasculitis” in the search box or your own individual form of vasculitis for studies specifically targeted towards patients like you.

Last Updated Start Date Study Name and Description ClinicalTrials.gov Identifier/Study Page Links
11/09/2023 Adults with Giant Cell Arteritis:  Give your feedback for the future of healthcare technology!
When:  Fall 2023 and January 2024
Where:  A city near you
Compensation available
What:  One 60-minute feedback session on a new medical device for GCA patients.
Sign up:  https://info.dscience.com/signup
10/18/2023 Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination with Glucocorticoid Taper Regimen, in Patients with Polymalgia Rheumatica (PMR) NCT05767034 PMR Patient Study Page
10/13/23 Clinical Transcriptomics in Systemic Vasculitis (CUTIS) (CUTIS) NCT03004326
10/11/23 Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis (THEIA)
*Active, not recruiting.
NCT04633447
10/11/23 A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS) NCT02939573
10/10/23 Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients with Giant Cell Arteritis (GCA) NCT04930094 GCA Patient Study Page
09/28/23 Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases (EPPIK) NCT05003986
09/15/23 Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases NCT00716066
09/11/23 Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis NCT02257866
09/11/23 A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis (SELECT-GCA)
*Active, not recruiting.
NCT03725202
09/07/23 Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA) (OCEAN) NCT05263934
08/31/23 PR-3 AAV Resilient Remission or PRRR NCT05376319
08/18/23 Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
*Enrolling by invitation.
NCT02638701
08/16/23 MANDARA Clinical Trial Enrolling Patients with EGPA
*Active, not recruiting.
NCT04157348
08/16/23 Efficacy and Safety of Benralizumab Compared to Mepolizumab (MANDARA)
*Active, not recruiting.
NCT04157348
08/14/23 Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener’s)
*Active, not recruiting.
NCT02108860
06/13/23 Abatacept for the Treatment of Giant Cell Arteritis
*Active, not recruiting.
 NCT04474847
05/30/23 Vasculitis Pregnancy Registry (V-PREG) NCT02593565
05/26/23 Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) NCT00315380
05/26/23 The Assessment of Prednisone in Remission Trial – Centers of Excellence Approach (TAPIR) NCT01940094
05/26/23 One-Time DNA Study for Vasculitis NCT01241305
05/15/23 Efficacy and Safety of Depemokimab Compared with Mepolizumab in Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA)(OCEAN) NCT05263934
03/29/23 Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease NCT04747847
03/28/23 Longitudinal Study for Central Nervous System Vasculitis NCT05734404
03/27/23 Defibrotide in Children With High Risk Kawasaki Disease NCT04777422
03/27/23 Longitudinal Study for Relapsing Polychondritis NCT04919538
02/21/23 AutoInflammatory Disease Alliance Registry (AIDA) (AIDA) NCT05200715
01/25/23 Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis NCT03906227
01/10/23 VCRC Tissue Repository NCT00315380
12/16/22 Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc) NCT03482479
12/02/22 A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives NCT05635266
11/29/22 Vascular Lab Resource (VLR) Biorepository NCT05628948
11/08/22 Pediatric Vasculitis Initiative (PedVas) NCT02006134
03/18/22 National Vaccine Adverse Event Reporting Survey and Etiology (NVAERS) NCT05095844
11/16/21 Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease NCT04538495
07/01/21 Polymyalgia Rheumatica Research Study Sanguine Patient Study Page
09/12/19 Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
*Unknown status.
NCT03066869
08/28/19 Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
*Unknown status.
NCT01917721
05/01/18 A Real World, Observational Registry of Chronic Wounds and Ulcers (USWR) NCT02280733